Biogen

High Court wrongly concluded public interest in cheaper drugs overrode patent holder rights, appeal court rules

There was ‘nothing unlawful’ in Biogen’s application for and exploitation of a parent patent

Wed Mar 29 2023 - 16:53

Hope on the horizon for families of thousands of Alzheimer’s patients

Giving doctors access to breakthrough medicines is priority for Biogen boss Michael O’Connell in his role as Irish Pharmaceutical Healthcare Association president

Fri Feb 24 2023 - 12:00

Alzheimer’s drug from Eisai and Biogen gets FDA accelerated approval

Trials showed €25,000 a year drug slowed rate of cognitive decline in patients with early Alzheimer’s by 27% compared to a placebo.

Fri Jan 06 2023 - 22:03

US regulator broke own protocols in approving Alzheimer’s drug

Congressional report says assessment of Biogen drug was ‘rife with irregularities’

Fri Dec 30 2022 - 13:54

Drug firm’s injunction that would cost taxpayer €8m refused

Pharma companies sought to prevent sale of generic multiple sclerosis drug

Thu Oct 27 2022 - 20:16

Biogen raises annual profit forecast for second straight quarter

Investors await more data on company’s new Alzheimer’s disease drug

Tue Oct 25 2022 - 15:57

Pharma sector promises ‘fitter and faster’ way to get drugs to market

Incoming Ipha president says industry expects to bring 30 new medicines to market in Ireland next year but warns on patent protection

Tue Sept 13 2022 - 05:45

Biogen CEO to step down as company pulls back on Alzheimer’s drug

Future of Aduhelm was in doubt after Medicare restricted coverage to clinical trials

Wed May 04 2022 - 08:06

European shares rise on China economic stimulus hopes

Markets report: Cairn soars 7.2 per cent on pledge to return €95m to investors this year

Wed Jan 12 2022 - 21:16

Markets lifted by investor optimism and US jobs data

Tech boom leads Wall Street indices to record highs

Thu Dec 30 2021 - 17:44

The State’s top 10 corporate taxpayers: who are they?

Corporation tax generated €11.8 billion in receipts last year, €1 in every €5 collected

Thu Dec 30 2021 - 14:53

European regulators cast doubt on Biogen Alzheimer’s treatment

EMA vote deals a setback to controversial $56,000-a-year treatment

Wed Nov 17 2021 - 15:32

Limerick-based Kneat shifts listing to main Canadian stock exchange

Software-as-a-Service company also reports surge in third quarter revenues

Tue Nov 16 2021 - 11:56

European shares hit new high but Dublin and London lag

Luxury goods groups Richemont and LVMH among standout performers

Fri Nov 12 2021 - 18:23

European stocks reach six-week highs as Nestlé shines

Strong results from Swiss group boost food stocks, offsetting losses elsewhere

Wed Oct 20 2021 - 20:14

Drug company Perrigo welcomes settlement of record tax bill

Company will pay over money within seven days of formal agreement being signed

Thu Sept 30 2021 - 12:54

Perrigo agrees €300m settlement of €1.64bn tax assessment

Tax dispute dates back to a 2016 audit by Revenue

Wed Sept 29 2021 - 23:00

Moody’s says Perrigo acquisition adds to Irish tax concerns

Ratings agency turns negative on outlook for ‘over-the-counter’ medicines group over potential debt burden

Fri Sept 10 2021 - 19:37

Dovish ECB and upbeat earnings support euro-zone stocks

ECB pledges to keep interest rates at record lows for even longer

Thu Jul 22 2021 - 18:44

Perrigo boss on the largest tax bill ever issued by Revenue

Business interview: CEO Murray Kessler talks Covid and sorting out Perrigo’s Irish tax bill

Fri Jul 16 2021 - 13:00

Ireland's largest tax bill falls 40% to €976m

Revenue Commissioners and Perrigo have been in intense discussions for months

Tue Jul 13 2021 - 22:05

Like Caesar’s wife, FDA must be above suspicion

Fallout from controversial approval of Alzheimer’s drug is a concern

Tue Jul 13 2021 - 05:39

Europe should approach new Alzheimer’s drug with care

A decision by the US FDA to approve aducanumab has alarmed many experts

Mon Jul 12 2021 - 06:01

Shares buoyed by hopes ECB will keep bond-buying scheme in place

Bank shares suffer as bond yields tighten

Fri Jun 11 2021 - 19:01

Stocks hover close to record highs on good day for airlines

Market edgy ahead of ECB policy decision and US inflation data

Wed Jun 09 2021 - 21:20

Is Biogen’s new Alzheimer’s drug a breakthrough or false hope?

Medical community sharply divided on the benefits of this drug in treating dementia

Wed Jun 09 2021 - 05:55

Biogen will charge $56,000-a-year for Alzheimer’s drug

Price over double the highest industry analyst estimate triggers renewed criticism

Tue Jun 08 2021 - 15:54

US regulators approve Alzheimer’s drug from Biogen

Many scientists opposed approval of controversial treatment, saying it did not work

Mon Jun 07 2021 - 17:38

Revenue rejects settlement offer on €1.64bn Perrigo tax bill

Consumer healthcare group hit with largest tax assessment ever issued by commissioners

Thu May 13 2021 - 13:22

Perrigo makes offer to Revenue on disputed €1.64bn tax bill

Amount is second-largest in the history of the State, behind only high-profile Apple case

Tue May 11 2021 - 19:32

Limerick-based software company Kneat secures €14.9m in financing

Irish-founded firm is listed on Toronto Stock Exchange but is run from Limerick

Tue May 04 2021 - 05:14

Warren Buffett pulls back on banks and bets on drug makers

Billionaire investor’s Berkshire Hathaway sinks $5.7bn into four US pharma stocks

Tue Nov 17 2020 - 13:00

Nikkei closes at near three-decade high as Biden edges closer to win

Investors hope a gridlock in US congress would be able to stall major policy changes

Fri Nov 06 2020 - 08:11

Biogen shares leap after ‘substantial evidence’ Alzheimer’s drug is effective

Aducanumab targets clumps of protein that can build up in the brain

Wed Nov 04 2020 - 17:23